Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001144204-17-025926
Filing Date
2017-05-10
Accepted
2017-05-10 13:42:38
Documents
39
Period of Report
2017-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q v465447_10q.htm 10-Q 162945
2 EXHIBIT 10.1 v465447_ex10-1.htm EX-10.1 11415
3 EXHIBIT 31.1 v465447_ex31-1.htm EX-31.1 8914
4 EXHIBIT 31.2 v465447_ex31-2.htm EX-31.2 8909
5 EXHIBIT 32.1 v465447_ex32-1.htm EX-32.1 4792
6 EXHIBIT 32.2 v465447_ex32-2.htm EX-32.2 4305
  Complete submission text file 0001144204-17-025926.txt   1858391

Data Files

Seq Description Document Type Size
7 XBRL INSTANCE DOCUMENT celz-20170331.xml EX-101.INS 235753
8 XBRL TAXONOMY EXTENSION SCHEMA celz-20170331.xsd EX-101.SCH 27601
9 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE celz-20170331_cal.xml EX-101.CAL 19006
10 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE celz-20170331_def.xml EX-101.DEF 184999
11 XBRL TAXONOMY EXTENSION LABEL LINKBASE celz-20170331_lab.xml EX-101.LAB 193763
12 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE celz-20170331_pre.xml EX-101.PRE 196472
Mailing Address 2017 W PEORIA AVENUE PHOENIX AZ 85029
Business Address 2017 W PEORIA AVENUE PHOENIX AZ 85029 (602) 680-7439
CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC. (Filer) CIK: 0001187953 (see all company filings)

EIN.: 870622284 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-53500 | Film No.: 17829545
SIC: 2836 Biological Products, (No Diagnostic Substances)